BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 29930471)

  • 1. Transarterial embolization and low-dose continuous hepatic arterial infusion chemotherapy with oxaliplatin and raltitrexed for hepatocellular carcinoma with major portal vein tumor thrombus.
    Zhu LZ; Xu S; Qian HL
    World J Gastroenterol; 2018 Jun; 24(23):2501-2507. PubMed ID: 29930471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis.
    Hu J; Bao Q; Cao G; Zhu X; Yang R; Ji X; Xu L; Zheng K; Li W; Xing B; Wang X
    Cardiovasc Intervent Radiol; 2020 Jul; 43(7):996-1005. PubMed ID: 31974744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma.
    Li JH; Xie XY; Zhang L; Le F; Ge NL; Li LX; Gan YH; Chen Y; Zhang JB; Xue TC; Chen RX; Xia JL; Zhang BH; Ye SL; Wang YH; Ren ZG
    World J Gastroenterol; 2015 Apr; 21(13):3970-7. PubMed ID: 25852283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus.
    Zhang ZH; Liu QX; Zhang W; Ma JQ; Wang JH; Luo JJ; Liu LX; Yan ZP
    World J Gastroenterol; 2017 Nov; 23(43):7735-7745. PubMed ID: 29209114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis.
    Zhang Y; Fan W; Wang Y; Lu L; Fu S; Yang J; Huang Y; Yao W; Li J
    Oncologist; 2015 Dec; 20(12):1417-24. PubMed ID: 26446238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study.
    Nagamatsu H; Sumie S; Niizeki T; Tajiri N; Iwamoto H; Aino H; Nakano M; Shimose S; Satani M; Okamura S; Kuromatsu R; Matsugaki S; Kurogi J; Kajiwara M; Koga H; Torimura T
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):243-50. PubMed ID: 26754678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
    He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
    Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study.
    Tan X; Xie P; Liu J; Wu H; Xie Y
    Asia Pac J Clin Oncol; 2015 Sep; 11(3):e6-e12. PubMed ID: 25228074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raltitrexed plus oxaliplatin-based transarterial chemoembolization in patients with unresectable hepatocellular carcinoma.
    Zhao C; Fan L; Qi F; Ou S; Yu L; Yi X; Ni B; Zheng Z; Lu J; Zhang C; Chen C; Lu X; Cheng L; Hu T; Ma Y
    Anticancer Drugs; 2016 Aug; 27(7):689-94. PubMed ID: 27145327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with intermediate and advanced stage hepatocellular carcinoma: A phase II, single-arm, prospective study.
    Chen S; Zhang K; Liu W; Yu W
    Eur J Cancer; 2020 Jul; 134():90-98. PubMed ID: 32497895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoembolization alone vs combined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patients.
    Gao S; Zhang PJ; Guo JH; Chen H; Xu HF; Liu P; Yang RJ; Zhu X
    World J Gastroenterol; 2015 Sep; 21(36):10443-52. PubMed ID: 26420971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
    Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis.
    Song DS; Bae SH; Song MJ; Lee SW; Kim HY; Lee YJ; Oh JS; Chun HJ; Lee HG; Choi JY; Yoon SK
    World J Gastroenterol; 2013 Aug; 19(29):4679-88. PubMed ID: 23922465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.
    Ye HH; Ye JZ; Xie ZB; Peng YC; Chen J; Ma L; Bai T; Chen JZ; Lu Z; Qin HG; Xiang BD; Li LQ
    World J Gastroenterol; 2016 Apr; 22(13):3632-43. PubMed ID: 27053855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant arterial infusion chemotherapy after resection of hepatocellular carcinoma with portal thrombosis: a pilot study.
    Niguma T; Mimura T; Tutui N
    J Hepatobiliary Pancreat Surg; 2005; 12(3):249-53. PubMed ID: 15995815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
    Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
    World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of hepatocellular carcinoma with tumor thrombi in the first branch of the portal vein and hepatic vein trunks treated by transcatheter hepatic arterial chemoembolization and hepatic arterial infusion chemotherapy--two years and six months follow-up].
    Haruno M; Shimamura R; Ogawa Y; Tanaka H; Sakai K; Araki K
    Gan To Kagaku Ryoho; 2005 May; 32(5):667-70. PubMed ID: 15918569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated I-125 Seed Implantation Combined with Transarterial Chemoembolization for Treatment of Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombus.
    Wang W; Wang C; Shen J; Ren B; Yin Y; Yang J; Tang H; Zhu X; Ni C
    Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1570-1578. PubMed ID: 34117503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raltitrexed and oxaliplatin hepatic arterial infusion for advanced colorectal cancer: a retrospective study.
    Khouri C; Guiu B; Cercueil JP; Chauffert B; Ladoire S; Ghiringhelli F
    Anticancer Drugs; 2010 Jul; 21(6):656-61. PubMed ID: 20216061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis.
    Georgiades CS; Hong K; D'Angelo M; Geschwind JF
    J Vasc Interv Radiol; 2005 Dec; 16(12):1653-9. PubMed ID: 16371532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.